GC
CDNA icon

Guggenheim Capital’s CareDx CDNA Stock Holding History

Guggenheim Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28,241
Closed -$501K – 1599
2025
Q1 		$501K Sell
28,241
-5,162
-15% -$111K ﹤0.01% 1199
2024
Q4 		$715K Sell
33,403
-6,728
-17% -$164K 0.01% 1092
2024
Q3 		$1.25M Sell
40,131
-1,686
-4% -$42K 0.01% 999
2024
Q2 		$649K Sell
41,817
-13,890
-25% -$168K ﹤0.01% 1319
2024
Q1 		$590K Sell
55,707
-2,210
-4% -$22.1K ﹤0.01% 1408
2023
Q4 		$695K Sell
57,917
-16,687
-22% -$137K 0.01% 1316
2023
Q3 		$522K Sell
74,604
-3,628
-5% -$33.5K ﹤0.01% 1400
2023
Q2 		$665K Buy
78,232
+17,910
+30% +$149K 0.01% 1336
2023
Q1 		$551K Sell
60,322
-47,697
-44% -$610K ﹤0.01% 1456
2022
Q4 		$1.23M Buy
108,019
+5,463
+5% +$81K 0.01% 1054
2022
Q3 		$1.75M Sell
102,556
-1,913
-2% -$41.1K 0.02% 889
2022
Q2 		$2.25M Buy
104,469
+4,277
+4% +$119K 0.02% 850
2022
Q1 		$3.71M Buy
100,192
+5,069
+5% +$198K 0.02% 773
2021
Q4 		$4.33M Buy
95,123
+22,472
+31% +$1.17M 0.02% 741
2021
Q3 		$4.6M Buy
72,651
+50,919
+234% +$3.88M 0.03% 692
2021
Q2 		$1.99M Buy
+21,732
New +$1.73M 0.01% 1102

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Guggenheim Capital's CDNA Position: Q2 2025 in Review

Guggenheim Capital sold out of CareDx (CDNA) in Q2 2025, closing a stake of 28,241 shares — an estimated $501K sold.

Guggenheim Capital first reported a position in CDNA in Q2 2021 and held it in 16 quarters. The position peaked at $4.6M in Q3 2021. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

  • Guggenheim Capital reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
  • Guggenheim Capital sold 28,241 CareDx shares in Q2 2025, an estimated $501K.
  • Guggenheim Capital first reported a position in CareDx in Q2 2021 and held it in 16 quarters.
  • Guggenheim Capital's CareDx position peaked at $4.6M in Q3 2021.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Guggenheim Capital's 13F filing for Q2 2025, filed 13 Aug 2025.